National cohort study of people with type 1 diabetes in France

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the relationship between glycemic variability, insulin therapy modalities, and cardiovascular risk in individuals with type 1 diabetes. Participants will be followed for 10 years through clinical visits and online follow-ups, allowing researchers to gather data on cardiovascular events and other related health outcomes. The study will include a diverse range of recruiting sites, including university hospitals and private practices, to ensure a comprehensive understanding of the factors influencing cardiovascular mortality in this population.

Why it matters

Who can join: the full rules

1. Inclusion Criteria

   * Adults and children (age \>= 6 years)
   * Type 1 diabetes, defined as:
   * Age at diagnosis of diabetes \> 1 year and \<= 35 years
   * Insulin treatment initiated within the first 12 months following diabetes discovery
   * Affiliation to the French social security scheme (RIPH-2 constraint)
   * Ability to speak and read French
   * Ability to give written informed consent
2. Non-inclusion Criteria Patient under guardianship or protection for vulnerable people

Where it's running

• Ffrd
  Paris, France Recruiting

Study contacts

• Study coordinator: Jean-Pierre Riveline, MD
• Email: jeanpierre.riveline@aphp.fr
• Phone: +33611416160

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Health Ahead: Comparing AI vs. Humans for Preventive Health Screening

  This study tests AI-assisted screening interpretation against human-only reads to see if automated screening can match or improve current practice for adults, especially in underserved areas.

  Recruiting Longevity Metrics, Inc. · Boulder, Colorado · NCT07669168

• Investigating the safety and effectiveness of porcine pancreatic cells in patients with Type 1 diabetes

  This study is testing if using pig pancreas cells can help adults with tough-to-manage Type 1 diabetes feel better and avoid dangerous low blood sugar episodes.

  Recruiting Phase 1/2 Otsuka Pharmaceutical Factory, Inc. · Chicago, Illinois · NCT06575426

• Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery

  This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.

  Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT07870941

• AI-powered ECG to help diagnose and predict outcomes in heart disease

  Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.

  Recruiting Inha University Hospital · Incheon, Incheon · NCT07856472

• Colchicine for preventing cardiovascular disease in adults with type 2 diabetes

  A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.

  Recruiting Phase 2 Tan Tock Seng Hospital · Singapore, Singapore · NCT07837934

• Optimised Cardio-Renal Care for CKD and heart disease

  This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.

  Recruiting Odense University Hospital · Svendborg · NCT07835828

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.